AMRN - AMARIN CORP PLC

14.06
-0.120   -0.853%

Share volume: 47,850
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$14.18
-0.12
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0.93%
1 Month
-4.68%
3 Months
-5.76%
6 Months
-4.84%
1 Year
48.47%
2 Year
48.47%
Key data
Stock price
$14.06
P/E Ratio 
N/A
DAY RANGE
$13.71 - $14.22
EPS 
N/A
52 WEEK RANGE
$8.32 - $20.90
52 WEEK CHANGE
$48.47
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$117,799
AVERAGE 30 VOLUME 
$87,415
Company detail
CEO: Karim Mikhail
Region: US
Website: www.amarincorp.com
Employees: 360
IPO year: 1993
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Amarin Corp. Plc is a biopharmaceutical company, which engages in the commercialization and development of therapeutics for cardiovascular health. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Recent news